metaEvidence - overview


			deaths (OS)
mML - NA - all population metastatic/adv melanoma (mML) mML - (neo)adjuvant (NA) mML - NA - all population
versus interferon alpha
	Ipilimumab (10 mg/kg) vs. interferon alpha	1	NaN [NaN; NaN] /10000 0/0 vs. 0/0
	ipilimumab alone vs. interferon alpha	1	NaN [NaN; NaN] /10000 0/0 vs. 0/0
versus Ipilimumab (10 mg/kg)
	nivolumab alone vs. Ipilimumab (10 mg/kg)	1	-243 [-793; 307] /10000 100/453 vs. 111/453
versus nivolumab alone
	nivolumab plus ipilimumab vs. nivolumab alone	1	-
versus placebo
	Ipilimumab (10 mg/kg) vs. placebo	1	-1085 [-1703; -468] /10000 162/475 vs. 214/476
	nivolumab alone vs. placebo	1	-
	nivolumab plus ipilimumab vs. placebo	1	-
	pembrolizumab alone vs. placebo	1	-